Insight into systematic development of ALK (anaplastic lymphoma kinase) inhibitors towards NSCLC treatment

Insight into systematic development of ALK (anaplastic lymphoma kinase) inhibitors towards NSCLC treatment

Among cancer-related disorders, lung carcinoma is one of the leading causes of mortality. Anaplastic lymphoma kinase (ALK) belongs to tyrosine kinase receptor family and exhibits similar characteristics to insulin type receptors. The treatment of advanced non-small cell lung cancer (NSCLC) associate...

Full description

Saved in:
Bibliographic Details
Main Authors: Vivek Yadav (Author), Jurnal Reang (Author), Vinita (Author), Prabodh Chander Sharma (Author), Kalicharan Sharma (Author), Deepak Kumar (Author), Rajiv Kumar Tonk (Author)
Format: Book
Published: Elsevier, 2024-04-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items